Intellipharmaceutics International Inc. Quarterly Stockholders' Equity Attributable to Parent in CAD from Q4 2013 to Q4 2018

Taxonomy & unit
us-gaap: CAD and USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Intellipharmaceutics International Inc. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q4 2013 to Q4 2018.
  • Intellipharmaceutics International Inc. Stockholders' Equity Attributable to Parent for the quarter ending November 30, 2018 was CA$4.1M, a 962% increase year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (CAD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2018 4.1M +3.72M +962% Nov 30, 2018 20-F/A 2019-03-04
Q4 2017 386K -730K -65.4% Nov 30, 2017 20-F/A 2019-03-04
Q2 2017 806K +2.72M May 31, 2017 6-K 2017-07-11
Q1 2017 871K +1.88M Feb 28, 2017 6-K 2017-04-12
Q4 2016 1.12M +1.25M Nov 30, 2016 20-F/A 2019-03-04
Q2 2016 -1.91M May 31, 2016 6-K 2017-07-11
Q1 2016 -1.01M Feb 29, 2016 6-K 2017-04-12
Q4 2015 -138K -5.05M -103% Nov 30, 2015 20-F/A 2019-03-04
Q4 2014 4.91M +10.9M Nov 30, 2014 20-F 2018-03-01
Q4 2013 -5.96M Nov 30, 2013 20-F 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.